Developing a novel glaucoma surgery for clinical use and commercialisation

开发一种用于临床和商业化的新型青光眼手术

• 批准号: nhmrc : 1116454
• 负责人: Prof Dao-Yi Yu
• 金额: $ 38.58万
• 依托单位: The University of Western Australia
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2019-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/developing-novel-glaucoma-use-commercialisation/946096
• 关键词: Developing; novel; glaucoma; surgery; clinical

Glaucoma is a potentially blinding eye condition that affects more than 60 million people. The greatest risk factor in glaucoma is high intraocular pressure. Surgical treatment for glaucoma seeks to lower the pressure inside the eye by increasing the drainage of fluid from the eye. There are numerous techniques available but all have risks of complications. This grant seeks to develop a novel approach to the problem using intra-ocular delivery of laser pulses to cut a drainage channel.

青光眼是一种可能导致失明的眼部疾病，影响着超过 6000 万人。青光眼的最大危险因素是高眼压。青光眼的手术治疗旨在通过增加眼内液体的排出来降低眼内压力。有多种技术可供选择，但都有并发症的风险。这笔赠款旨在开发一种新的方法来解决该问题，使用眼内传输激光脉冲来切割引流通道。